GLP-1 Weight Loss Articles & Guides

Complete guide on optimal timing for tirzepatide injections, including best day of week, time of day, and food considerations.

• Best day of week guidance
• Time of day recommendations
• Food & meal timing tips
• Consistency strategies

Complete injection site guide covering abdomen, thigh, and upper arm. Learn proper technique, site rotation, and tips for comfortable injections.

• 3 injection sites explained
• Proper technique guide
• Site rotation schedule
• Comfort tips & mistakes

Complete Mounjaro/Zepbound injection guide covering sites, technique for larger volume injections, and rotation for tirzepatide.

• 3 injection sites explained
• Larger volume technique
• Count to 10 guidance
• Comfort tips for 0.5ml

Complete timing guide for Ozempic/Wegovy covering best day of week, time of day, with/without food, and consistency strategies.

• Best day of week analysis
• Morning vs evening timing
• Food considerations
• Schedule change guidance

Complete timing guide for Mounjaro/Zepbound covering best day of week, time of day, with/without food, and tirzepatide-specific considerations.

• Best day of week analysis
• 4-day flexible window
• Food considerations
• 20-25% weight loss results

28 telehealth providers compared on the numbers they actually publish. Membership fees separated from medication cost, so you can see the real monthly total.

• 28 providers side by side
• Real cost, not headline price
• Manufacturer-direct benchmarks
• Prepayment traps flagged

The oral GLP-1 pill the FDA approved on April 1, 2026. Dosing from 0.8 mg, self-pay pricing from $149/mo, weight loss results and side effects.

• FDA approved April 2026
• No injections or refrigeration
• Full dosing schedule
• From $149/month self-pay

What a GLP-1 actually costs across six routes, from $50/month on Medicare to $1,349 at retail. Includes the two-part pricing trap most comparisons miss.

• Every route priced out
• Cost by medication
• Dose escalation warning
• Find your cheapest route

Medicare now covers Foundayo, Wegovy and the Zepbound KwikPen at $50/month for eligible beneficiaries, from July 1, 2026 through December 31, 2027.

• $50/month coverage
• Three covered products
• Eligibility criteria
• Compared to cash pricing

The SURMOUNT-5 head-to-head trial found 20.2% average weight loss on tirzepatide against 13.7% on semaglutide. What that means, and what it does not settle.

• Head-to-head trial data
• Mechanism explained
• Side effects compared
• Cost by molecule

What the FDA changed in 2026, why compounded GLP-1s narrowed, and how manufacturer pricing at $149/mo closed the gap that justified the trade-off.

• FDA position explained
• When compounded still fits
• Insurance eligibility
• How to reduce risk

"GLP-1 supplement" covers two completely different products. Boosters claim to raise your own GLP-1 and have almost no clinical evidence. Companion supplements fill real nutrient gaps and do.

• Boosters vs companions
• What the evidence shows
• Brand-by-brand breakdown
• FDA safety warnings

The first and only FDA-approved medication for obstructive sleep apnea. SURMOUNT-OSA showed a 58.7% AHI reduction vs 2.5% on placebo — and the indication can unlock coverage weight loss alone cannot.

• First drug approved for OSA
• 58.7% AHI reduction
• Coverage implications
• How it compares to CPAP

Six GLP-1 supplements compared on published ingredient amounts, evidence quality and real cost. Position one is a paid placement, disclosed on the page; the rest are editorial.

• Full ingredient amounts
• Evidence limits stated
• Paid placement disclosed
• Cheaper alternatives flagged